Form D filings in Ireland.
82 Form D notices were filed by issuers based in Ireland in Q2 2026 and Q3 2026, 15 new and 67 amendments. 97.6% claimed Rule 506(b) and 2.4% Rule 506(c).
- Notices
- 82
- Amendments
- 67
- Rule 506(c)
- 2.4%
- Pooled funds
- 93.9%
- Amount sold, new notices
- $731.0M
- Latest filing
- 2026-09-30
Latest notices
| Filed | Issuer | Industry | Type | Amount sold | Offering size | Exemptions |
|---|---|---|---|---|---|---|
| 2026-09-30 | Baillie Gifford Private Companies Fund III (Lux) SCSp | Pooled Investment Fund | D/A | $29.2M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-30 | Exponent Ireland, ILP | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-24 | Shenkman Multi-Asset Credit Fund | Pooled Investment Fund | D/A | $764.3M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-24 | Petrus Advisers Active Value Master Fund, a sub-fund of Petrus Advisers Master ICAV | Pooled Investment Fund | D/A | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-24 | Petrus Advisers Active Value Feeder Fund, a sub-fund of Petrus Advisers Feeder ICAV | Pooled Investment Fund | D/A | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-23 | Prusik Asian Equity Income Fund | Pooled Investment Fund | D/A | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-16 | Marshall Wace Long Strategies ICAV - MW TOPS Emerging Markets Fund | Pooled Investment Fund | D/A | $806.2M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-10 | Shenkman Multi-Asset Credit Values Screening Fund | Pooled Investment Fund | D/A | $279.6M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-09 | OGV - Quickpoint Limited Partnership | Pooled Investment Fund | D | $16.4M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1) |
| 2026-09-08 | Wilshire Bridgewater Managed Alpha (Ireland) Fund, a sub fund of Wilshire Solutions ICAV | Pooled Investment Fund | D/A | $349.6M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-08 | DAVION HEALTHCARE PLC | Other Health Care | D | $350K | $10.0M | Rule 506(b) |
| 2026-09-08 | GSA QMS FUND LP | Pooled Investment Fund | D/A | $295.9M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-09-08 | GSA INTERNATIONAL FUND LP | Pooled Investment Fund | D/A | $367.6M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-28 | Incentive Active Value Long Only Fund - a sub-fund of Incentive Investment Funds Plc | Pooled Investment Fund | D/A | $1.90B | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1) |
| 2026-08-25 | Fortress Lending Fund V (U-B) I.L.P. | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-21 | Pilgrim Global ICAV | Pooled Investment Fund | D/A | $226.1M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-19 | ICG CLO Investment Partners II Designated Activity Co | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-19 | AKO UCITS FUND ICAV - AKO Global Long-Only UCITS Fund | Pooled Investment Fund | D/A | $150.0M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-18 | Impact Ireland USA, LP | Pooled Investment Fund | D/A | $75.7M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1) |
| 2026-08-13 | Fortress Lending Fund V (U-A) I.L.P. | Pooled Investment Fund | D | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-13 | Fusion Fuel Green PLC | Other Energy | D | $1.5M | $1.5M | Rule 506(b) |
| 2026-08-10 | Fortis Medical Devices Teoranta | Other Health Care | D | $450K | $1.7M | Rule 506(b) |
| 2026-08-07 | Emerald Global Water Fund II, a sub-fund of Emerald Innovation Fund ILP | Pooled Investment Fund | D/A | $45.0M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-07 | PGIM Qualifying Investor Funds plc | Pooled Investment Fund | D/A | $149.6M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-08-03 | W4 Games US Inc. | Other Technology | D | $3.1M | $3.1M | Rule 506(b) |
| 2026-07-31 | Incentive Special Opportunities Fund - a sub-fund of Incentive Investment Funds ICAV | Pooled Investment Fund | D/A | $25.0M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(1) |
| 2026-07-30 | Focus Fund | Pooled Investment Fund | D | $30.0M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-07-23 | PGIM Capital Partners (Parallel Fund) VII, L.P. | Pooled Investment Fund | D/A | $0 | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-07-17 | Marshall Wace Funds PLC - MW Global Opportunities Fund | Pooled Investment Fund | D/A | $740.6M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
| 2026-07-17 | Marshall Wace Funds PLC - MW Global Financials Market Neutral Fund | Pooled Investment Fund | D/A | $12.0M | Indefinite | Rule 506(b), Investment Company Act 3(c), 3(c)(7) |
Median minimum investment accepted, among the 16 notices above that report one: $600,000.
Query these notices
The Form D offerings endpoint returns every notice for a quarter with all issuer identities and source strings. Filter by issuer CIK, or page through a quarter and group by industry or location yourself.
curl "https://sec-api.dev/api/v1/offerings?period=2026q3&limit=25" \
-H "Authorization: Bearer $SEC_API_KEY"Questions
How many Form D filings came from Ireland?
82 Form D notices were filed by issuers based in Ireland in Q2 2026 and Q3 2026, 15 new and 67 amendments. 97.6% claimed Rule 506(b) and 2.4% Rule 506(c).
Does amount sold equal money raised this quarter?
No. The total amount sold on a notice is cumulative for the offering. Use new notices, or the latest amendment per offering, to avoid double counting.
Other locations
Plain-text version for agents and LLMs: /form-d/locations/ireland.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.